首页> 外国专利> PRODUCTION OF SOLID ORAL DOSAGE FORM OF METFORMIN AND GLYBURIDE BY HOMOGENIZING GLYBURIDE IN ORGANIC SOLUTION, SPRAYING SLURRY ONTO PHARMACEUTICAL EXCIPIENTS AND THEN MIXING WITH METFORMIN GRANULES HAVING EFFECT OF EXHIBITING BIOAVAILABILITY AND SOLUBILITY EQUAL TO CONVENTIONAL GLUCOVANCE AND BEING USED IN TREATMENT OF NON-INSULIN DEPENDENT DIABETES

PRODUCTION OF SOLID ORAL DOSAGE FORM OF METFORMIN AND GLYBURIDE BY HOMOGENIZING GLYBURIDE IN ORGANIC SOLUTION, SPRAYING SLURRY ONTO PHARMACEUTICAL EXCIPIENTS AND THEN MIXING WITH METFORMIN GRANULES HAVING EFFECT OF EXHIBITING BIOAVAILABILITY AND SOLUBILITY EQUAL TO CONVENTIONAL GLUCOVANCE AND BEING USED IN TREATMENT OF NON-INSULIN DEPENDENT DIABETES

机译:通过在有机溶液中均质化乙交酯,将淤泥喷洒到药物赋形剂上来生产二甲双胍和乙交酯的固体口服剂型,然后将其与二甲双胍颗粒混合,可以有效地证明其持续性一直有效

摘要

PURPOSE: A simple and easy method for the preparation of solid oral dosages of the combination of metformin and glyburide by homogenizing glyburide in an organic solution, spraying resulted slurry onto pharmaceutical excipients and then mixing with metformin granules is provided. The product exhibits bioavailability and solubility equal to conventional Glucovance and is used in treatment of non-insulin dependent diabetes by administering to a patient in need thereof. CONSTITUTION: The solid oral dosages are prepared by the steps of: obtaining a slurry by homogenizing glyburide in an organic solution at 5,000 to 50,000rpm; spraying the resulted slurry onto pharmaceutical excipients; mixing the resulted product with metformin granules; forming the solid oral dosage of metformin and glyburide; and additionally screening the slurry with a sieve of 45m in diameter. The slurry contains about 8 to 15% by weight of glyburide in soluble form and remaining glyburide in particle form with a diameter of 45m or less. The organic solution is selected from the group consisting of methanol, ethanol or lower alkanol having 1-6C and mixtures thereof. The weight ratio of glyburide and organic solution is 1/10 to 1/40.
机译:目的:提供一种简单易行的方法,可通过在有机溶液中均化格列本脲,将所得的浆液喷雾到药物赋形剂上,然后与二甲双胍颗粒混合,来制备二甲双胍和格列本脲组合的固体口服剂型。该产品具有与常规Glucovance相同的生物利用度和溶解度,可通过向有需要的患者给药来用于治疗非胰岛素依赖型糖尿病。组成:固体口服剂的制备步骤为:在有机溶液中以5,000至50,000rpm均化格列本脲制得浆液;将所得浆液喷雾到药物赋形剂上;将所得产物与二甲双胍颗粒混合;形成二甲双胍和格列本脲的固体口服剂量;并另外用直径为45m的筛子筛分浆液。该浆料包含约8至15重量%的可溶形式的格列本脲和剩余的直径为45m或更小的颗粒形式的格列本脲。有机溶液选自具有1-6℃的甲醇,乙醇或低级链烷醇及其混合物。格列本脲与有机溶液的重量比为1/10至1/40。

著录项

相似文献

  • 专利
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号